日本の高齢化の健康像に新たな知見(Swedish study adds nuances to the picture of healthy Japanese ageing)

ad

2026-03-23 カロリンスカ研究所(KI)

スウェーデンのカロリンスカ研究所の研究は、「日本人は健康に長生きする」という従来のイメージに新たな視点を加えた。調査では、日本の高齢者は平均寿命や身体機能の維持で優れる一方、慢性疾患の有病率や機能低下の進行には個人差があり、必ずしも一様に「健康長寿」とは言えないことが示された。また社会的孤立や生活習慣の違いなどが健康状態に影響を与える可能性も指摘された。研究は、長寿の質を評価するには多面的な指標が必要であり、日本の高齢化モデルも再評価すべきだと結論づけている。

<関連情報>

日本の死亡率優位性を理解する:日本とスウェーデンの自立高齢者と要介護高齢者の死亡率の比較 Understanding Japan’s mortality advantage: a comparison of mortality in independent and dependent older adults in Japan and Sweden

Shunsuke Murata,Marcus Ebeling,Rei Ono,Megumi Maeda,Katharina Schmidt‑Mende,Haruhisa Fukuda & Karin Modig
BMC Medicine  Published:23 March 2026
DOI:https://doi.org/10.1186/s12916-026-04786-z

日本の高齢化の健康像に新たな知見(Swedish study adds nuances to the picture of healthy Japanese ageing)日本の高齢化の健康像に新たな知見(Swedish study adds nuances to the picture of healthy Japanese ageing)

Abstract

Background

A fundamental public health goal is that all individuals have the opportunity to reach old age with adequate care and support. Japan is the global leader in longevity, and understanding whether this advantage exists primarily in healthy older adults or those relying on long-term care (LTC) can reveal if it stems from a healthier population or more extensive, and potentially higher-quality, healthcare provision. This study examined Japan’s mortality advantage by comparing life expectancy and death rates in Japan and Sweden across different levels of LTC.

Methods

We included the entire population aged 75 + in Sweden (n = 858,595) and nine Japanese municipalities (n = 334,873), categorizing individuals into three groups: no care, home care, and care home residence. We compared age-specific death rates, remaining life expectancy, and expected time spent in each LTC state. Finally, we quantified how much of the overall mortality differences could be explained by LTC state-specific mortality difference.

Results

Japanese older adults had lower death rates and longer life expectancy than Swedish counterparts, with more pronounced differences among individuals utilizing LTC. At age 75, total life expectancy was 12.0 vs. 11.7 years for men and 15.5 vs. 13.7 years for women in Japan and Sweden, respectively. Expected time without LTC was 9.8 vs. 9.6 years for men and 10.4 vs. 9.9 years for women. The difference (95% CI) in total life expectancy [men, 0.3 (0.2, 0.4); women, 1.8 (1.7, 1.9)] exceeded the difference in time without LTC [men, 0.2 (0.2, 0.3); women, 0.5 (0.4, 0.5)], particularly for women. Higher mortality in home care and care home populations in Sweden substantially increased Japan’s advantage.

Conclusions

Our findings show that Japan’s longevity advantage in old age is primarily driven by lower mortality in the segment of the population utilizing LTC. This indicates that the overall advantage in life expectancy may not stem solely from a healthier population, but rather from more extensive, or possibly higher-quality, care, including life-sustaining treatments. However, since we were unable to control for differences in health status in the two populations, future studies should explore if the threshold for entering LTC is different in Sweden and Japan.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました